Pharmaceutical

Molecular glues are the latest craze in pharma research...

Deals involving research into molecular glues have skyrocketed this year as big ...

NVIDIA doubles down on AI in healthcare with drug disco...

In addition to drug discovery deals, NVIDIA also announced partnerships with J&J...

Eli Lilly’s partnership with Amazon to boost presence i...

Eli Lilly's LillyDirect allows for online consultations and prescriptions, and A...

Asieris showcases Phase III win in treating precancerou...

Asieris presented positive Phase III results at the 2024 Society of Gynecologic ...

AstraZeneca to acquire radioconjugate biotech Fusion in...

As AstraZeneca looks to move past chemotherapy and radiotherapy, it will enter a...

China NMPA approves KeChow’s tunlametinib for melanoma

The China NMPA has granted approval to KeChow Pharma's tunlametinib for treating...

Microsoft and NVIDIA expand collaboration in healthcare...

Microsoft has announced plans to broaden its partnership with NVIDIA to leverage...

Bristol Myers Squibb acquires Karuna Therapeutics for $...

Bristol Myers Squibb (BMS) has concluded the acquisition of Karuna Therapeutics ...

Is HIV-TB coinfection treatment entering a new frontier?

TB is the leading determiner of death in patients with HIV, yet while new drug r...

Biden’s administration initiative aims to advance women...

The new initiative aims to spur innovation and mobilisation of sectors to drive ...

FDA approves Madrigal’s Rezdiffra as the first NASH the...

Madrigal’s Rezdiffra received an accelerated approval as a treatment for noncirr...

Biotheus and Hansoh Pharmaceutical expand ADC collabora...

Biotheus has announced an expansion of its strategic partnership with Hansoh Pha...

Anocca signs licensing deal for EmendoBio’s gene-editin...

Anocca has entered a licensing agreement with EmendoBio for the use of the latte...

Noramco launches North American pharma supply chain ser...

Noramco has announced the launch of Noramco Group, a North American pharmaceutic...

FDA approves BeiGene’s TEVIMBRA for oesophageal cancer

The US FDA has approved BeiGene's TEVIMBRA for oesophageal squamous cell carcino...